Donna Dundon
Family · Scottsdale, AZNPI 1972666295
Payments from drug & device makers
Across 85 payments — averaging $32.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$664
- Novartis$405
- AbbVie$392
- UCB, Inc.$292
- Argenx US, Inc.$169
- Acadia Pharmaceuticals Inc$125
- plus $683 from 21 others
What the payments were for
- Food & beverage$2,70599%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 11 | $664 |
| Novartis | 5 | $405 |
| AbbVie | 16 | $392 |
| UCB, Inc. | 10 | $292 |
| Argenx US, Inc. | 4 | $169 |
| Acadia Pharmaceuticals Inc | 6 | $125 |
| MDD US Operations, LLC | 2 | $73 |
| Bristol Myers Squibb | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 2 | $66 |
| Eisai Inc. | 2 | $48 |
| Cala Health, Inc. | 1 | $41 |
| Lundbeck LLC | 2 | $40 |
| Pfizer | 2 | $34 |
| Lilly USA, LLC | 2 | $28 |
| Genentech USA, Inc. | 2 | $28 |
| Neurelis, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Almatica Pharma LLC | 2 | $24 |
| Aprecia Pharmaceuticals, LLC | 1 | $22 |
| Corium, LLC | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| GE HealthCare | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,729 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 39 | $340,723 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 16 | $186,857 |
| RebifInterferon Beta-1a/Albumin | 17 | $178,773 |
| VumerityDiroximel Fumarate | 13 | $128,982 |
| CopaxoneGlatiramer Acetate | 12 | $84,619 |
| RytaryCarbidopa/Levodopa | 40 | $50,565 |
| UbrelvyUbrogepant | 29 | $35,479 |
| Nurtec OdtRimegepant Sulfate | 26 | $33,188 |
| Glatiramer Acetate | 13 | $30,999 |
| Emgality PenGalcanezumab-Gnlm | 43 | $29,908 |
| Dimethyl Fumarate | 16 | $24,588 |
| Galantamine ErGalantamine Hbr | 193 | $14,375 |
| Hysingla ErHydrocodone Bitartrate | 13 | $11,399 |
| Zembrace SymtouchSumatriptan Succinate | 13 | $10,383 |
| Dalfampridine ErDalfampridine | 31 | $8,694 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $26 | $186,85716 claims |
| BiogenVumerity | $664 | $128,98213 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $66 | $84,61912 claims |
| AbbVieUbrelvy | $392 | $35,47929 claims |
| PfizerNurtec Odt | $34 | $33,18826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,119 family providers in Arizona.
Other family in Scottsdale
- Kaitlyn LouchheimScottsdale$208K
- Jennifer PrinceScottsdale$76K
- Camilla BinksScottsdale$62K
- Jessica TapiaScottsdale$36K
- Dawn MougelScottsdale$34K
- Keegan RussellScottsdale$28K
- Jamie HowardScottsdale$14K
- Anna CramerScottsdale$14K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.